Cancidas Market, Global Outlook and Forecast 2024-2031

Report ID: 1068745 | Published Date: Jan 2025 | No. of Page: 73 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
1 Introduction to Research & Analysis Reports
    1.1 Cancidas Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Cancidas Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Cancidas Overall Market Size
    2.1 Global Cancidas Market Size: 2021 VS 2028
    2.2 Global Cancidas Revenue, Prospects & Forecasts: 2017-2028
    2.3 Global Cancidas Sales: 2017-2028
3 Company Landscape
    3.1 Top Cancidas Players in Global Market
    3.2 Top Global Cancidas Companies Ranked by Revenue
    3.3 Global Cancidas Revenue by Companies
    3.4 Global Cancidas Sales by Companies
    3.5 Global Cancidas Price by Manufacturer (2017-2022)
    3.6 Top 3 and Top 5 Cancidas Companies in Global Market, by Revenue in 2021
    3.7 Global Manufacturers Cancidas Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Cancidas Players in Global Market
        3.8.1 List of Global Tier 1 Cancidas Companies
        3.8.2 List of Global Tier 2 and Tier 3 Cancidas Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Cancidas Market Size Markets, 2021 & 2028
        4.1.2 Injection Product
        4.1.3 Table Product
        4.1.4 Others
    4.2 By Type - Global Cancidas Revenue & Forecasts
        4.2.1 By Type - Global Cancidas Revenue, 2017-2022
        4.2.2 By Type - Global Cancidas Revenue, 2023-2028
        4.2.3 By Type - Global Cancidas Revenue Market Share, 2017-2028
    4.3 By Type - Global Cancidas Sales & Forecasts
        4.3.1 By Type - Global Cancidas Sales, 2017-2022
        4.3.2 By Type - Global Cancidas Sales, 2023-2028
        4.3.3 By Type - Global Cancidas Sales Market Share, 2017-2028
    4.4 By Type - Global Cancidas Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
    5.1 Overview
        5.1.1 By Application - Global Cancidas Market Size, 2021 & 2028
        5.1.2 Adult
        5.1.3 Child
    5.2 By Application - Global Cancidas Revenue & Forecasts
        5.2.1 By Application - Global Cancidas Revenue, 2017-2022
        5.2.2 By Application - Global Cancidas Revenue, 2023-2028
        5.2.3 By Application - Global Cancidas Revenue Market Share, 2017-2028
    5.3 By Application - Global Cancidas Sales & Forecasts
        5.3.1 By Application - Global Cancidas Sales, 2017-2022
        5.3.2 By Application - Global Cancidas Sales, 2023-2028
        5.3.3 By Application - Global Cancidas Sales Market Share, 2017-2028
    5.4 By Application - Global Cancidas Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
    6.1 By Region - Global Cancidas Market Size, 2021 & 2028
    6.2 By Region - Global Cancidas Revenue & Forecasts
        6.2.1 By Region - Global Cancidas Revenue, 2017-2022
        6.2.2 By Region - Global Cancidas Revenue, 2023-2028
        6.2.3 By Region - Global Cancidas Revenue Market Share, 2017-2028
    6.3 By Region - Global Cancidas Sales & Forecasts
        6.3.1 By Region - Global Cancidas Sales, 2017-2022
        6.3.2 By Region - Global Cancidas Sales, 2023-2028
        6.3.3 By Region - Global Cancidas Sales Market Share, 2017-2028
    6.4 North America
        6.4.1 By Country - North America Cancidas Revenue, 2017-2028
        6.4.2 By Country - North America Cancidas Sales, 2017-2028
        6.4.3 US Cancidas Market Size, 2017-2028
        6.4.4 Canada Cancidas Market Size, 2017-2028
        6.4.5 Mexico Cancidas Market Size, 2017-2028
    6.5 Europe
        6.5.1 By Country - Europe Cancidas Revenue, 2017-2028
        6.5.2 By Country - Europe Cancidas Sales, 2017-2028
        6.5.3 Germany Cancidas Market Size, 2017-2028
        6.5.4 France Cancidas Market Size, 2017-2028
        6.5.5 U.K. Cancidas Market Size, 2017-2028
        6.5.6 Italy Cancidas Market Size, 2017-2028
        6.5.7 Russia Cancidas Market Size, 2017-2028
        6.5.8 Nordic Countries Cancidas Market Size, 2017-2028
        6.5.9 Benelux Cancidas Market Size, 2017-2028
    6.6 Asia
        6.6.1 By Region - Asia Cancidas Revenue, 2017-2028
        6.6.2 By Region - Asia Cancidas Sales, 2017-2028
        6.6.3 China Cancidas Market Size, 2017-2028
        6.6.4 Japan Cancidas Market Size, 2017-2028
        6.6.5 South Korea Cancidas Market Size, 2017-2028
        6.6.6 Southeast Asia Cancidas Market Size, 2017-2028
        6.6.7 India Cancidas Market Size, 2017-2028
    6.7 South America
        6.7.1 By Country - South America Cancidas Revenue, 2017-2028
        6.7.2 By Country - South America Cancidas Sales, 2017-2028
        6.7.3 Brazil Cancidas Market Size, 2017-2028
        6.7.4 Argentina Cancidas Market Size, 2017-2028
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Cancidas Revenue, 2017-2028
        6.8.2 By Country - Middle East & Africa Cancidas Sales, 2017-2028
        6.8.3 Turkey Cancidas Market Size, 2017-2028
        6.8.4 Israel Cancidas Market Size, 2017-2028
        6.8.5 Saudi Arabia Cancidas Market Size, 2017-2028
        6.8.6 UAE Cancidas Market Size, 2017-2028
7 Manufacturers & Brands Profiles
    7.1 Fresenius SE & Co. KGaA (Fresenius Kabi)
        7.1.1 Fresenius SE & Co. KGaA (Fresenius Kabi) Corporate Summary
        7.1.2 Fresenius SE & Co. KGaA (Fresenius Kabi) Business Overview
        7.1.3 Fresenius SE & Co. KGaA (Fresenius Kabi) Cancidas Major Product Offerings
        7.1.4 Fresenius SE & Co. KGaA (Fresenius Kabi) Cancidas Sales and Revenue in Global (2017-2022)
        7.1.5 Fresenius SE & Co. KGaA (Fresenius Kabi) Key News
    7.2 Alvogen Inc.
        7.2.1 Alvogen Inc. Corporate Summary
        7.2.2 Alvogen Inc. Business Overview
        7.2.3 Alvogen Inc. Cancidas Major Product Offerings
        7.2.4 Alvogen Inc. Cancidas Sales and Revenue in Global (2017-2022)
        7.2.5 Alvogen Inc. Key News
    7.3 Juno Pharmaceuticals (MDA Inc.)
        7.3.1 Juno Pharmaceuticals (MDA Inc.) Corporate Summary
        7.3.2 Juno Pharmaceuticals (MDA Inc.) Business Overview
        7.3.3 Juno Pharmaceuticals (MDA Inc.) Cancidas Major Product Offerings
        7.3.4 Juno Pharmaceuticals (MDA Inc.) Cancidas Sales and Revenue in Global (2017-2022)
        7.3.5 Juno Pharmaceuticals (MDA Inc.) Key News
    7.4 Cipla Inc.
        7.4.1 Cipla Inc. Corporate Summary
        7.4.2 Cipla Inc. Business Overview
        7.4.3 Cipla Inc. Cancidas Major Product Offerings
        7.4.4 Cipla Inc. Cancidas Sales and Revenue in Global (2017-2022)
        7.4.5 Cipla Inc. Key News
    7.5 Merck & Co., Inc.
        7.5.1 Merck & Co., Inc. Corporate Summary
        7.5.2 Merck & Co., Inc. Business Overview
        7.5.3 Merck & Co., Inc. Cancidas Major Product Offerings
        7.5.4 Merck & Co., Inc. Cancidas Sales and Revenue in Global (2017-2022)
        7.5.5 Merck & Co., Inc. Key News
    7.6 Athenex, Inc.
        7.6.1 Athenex, Inc. Corporate Summary
        7.6.2 Athenex, Inc. Business Overview
        7.6.3 Athenex, Inc. Cancidas Major Product Offerings
        7.6.4 Athenex, Inc. Cancidas Sales and Revenue in Global (2017-2022)
        7.6.5 Athenex, Inc. Key News
    7.7 Sanofi S.A.
        7.7.1 Sanofi S.A. Corporate Summary
        7.7.2 Sanofi S.A. Business Overview
        7.7.3 Sanofi S.A. Cancidas Major Product Offerings
        7.7.4 Sanofi S.A. Cancidas Sales and Revenue in Global (2017-2022)
        7.7.5 Sanofi S.A. Key News
    7.8 Sundent Pharmaceutical Co. Ltd.
        7.8.1 Sundent Pharmaceutical Co. Ltd. Corporate Summary
        7.8.2 Sundent Pharmaceutical Co. Ltd. Business Overview
        7.8.3 Sundent Pharmaceutical Co. Ltd. Cancidas Major Product Offerings
        7.8.4 Sundent Pharmaceutical Co. Ltd. Cancidas Sales and Revenue in Global (2017-2022)
        7.8.5 Sundent Pharmaceutical Co. Ltd. Key News
    7.9 Gland Pharma Limited
        7.9.1 Gland Pharma Limited Corporate Summary
        7.9.2 Gland Pharma Limited Business Overview
        7.9.3 Gland Pharma Limited Cancidas Major Product Offerings
        7.9.4 Gland Pharma Limited Cancidas Sales and Revenue in Global (2017-2022)
        7.9.5 Gland Pharma Limited Key News
    7.10 Sun Pharmaceutical Industries Ltd.
        7.10.1 Sun Pharmaceutical Industries Ltd. Corporate Summary
        7.10.2 Sun Pharmaceutical Industries Ltd. Business Overview
        7.10.3 Sun Pharmaceutical Industries Ltd. Cancidas Major Product Offerings
        7.10.4 Sun Pharmaceutical Industries Ltd. Cancidas Sales and Revenue in Global (2017-2022)
        7.10.5 Sun Pharmaceutical Industries Ltd. Key News
8 Global Cancidas Production Capacity, Analysis
    8.1 Global Cancidas Production Capacity, 2017-2028
    8.2 Cancidas Production Capacity of Key Manufacturers in Global Market
    8.3 Global Cancidas Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Cancidas Supply Chain Analysis
    10.1 Cancidas Industry Value Chain
    10.2 Cancidas Upstream Market
    10.3 Cancidas Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Cancidas Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer
List of Tables
    Table 1. Key Players of Cancidas in Global Market
    Table 2. Top Cancidas Players in Global Market, Ranking by Revenue (2021)
    Table 3. Global Cancidas Revenue by Companies, (US$, Mn), 2017-2022
    Table 4. Global Cancidas Revenue Share by Companies, 2017-2022
    Table 5. Global Cancidas Sales by Companies, (K Units), 2017-2022
    Table 6. Global Cancidas Sales Share by Companies, 2017-2022
    Table 7. Key Manufacturers Cancidas Price (2017-2022) & (US$/Unit)
    Table 8. Global Manufacturers Cancidas Product Type
    Table 9. List of Global Tier 1 Cancidas Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Cancidas Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Cancidas Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Global Cancidas Revenue (US$, Mn), 2017-2022
    Table 13. By Type - Global Cancidas Revenue (US$, Mn), 2023-2028
    Table 14. By Type - Global Cancidas Sales (K Units), 2017-2022
    Table 15. By Type - Global Cancidas Sales (K Units), 2023-2028
    Table 16. By Application – Global Cancidas Revenue, (US$, Mn), 2021 & 2028
    Table 17. By Application - Global Cancidas Revenue (US$, Mn), 2017-2022
    Table 18. By Application - Global Cancidas Revenue (US$, Mn), 2023-2028
    Table 19. By Application - Global Cancidas Sales (K Units), 2017-2022
    Table 20. By Application - Global Cancidas Sales (K Units), 2023-2028
    Table 21. By Region – Global Cancidas Revenue, (US$, Mn), 2021 VS 2028
    Table 22. By Region - Global Cancidas Revenue (US$, Mn), 2017-2022
    Table 23. By Region - Global Cancidas Revenue (US$, Mn), 2023-2028
    Table 24. By Region - Global Cancidas Sales (K Units), 2017-2022
    Table 25. By Region - Global Cancidas Sales (K Units), 2023-2028
    Table 26. By Country - North America Cancidas Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - North America Cancidas Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - North America Cancidas Sales, (K Units), 2017-2022
    Table 29. By Country - North America Cancidas Sales, (K Units), 2023-2028
    Table 30. By Country - Europe Cancidas Revenue, (US$, Mn), 2017-2022
    Table 31. By Country - Europe Cancidas Revenue, (US$, Mn), 2023-2028
    Table 32. By Country - Europe Cancidas Sales, (K Units), 2017-2022
    Table 33. By Country - Europe Cancidas Sales, (K Units), 2023-2028
    Table 34. By Region - Asia Cancidas Revenue, (US$, Mn), 2017-2022
    Table 35. By Region - Asia Cancidas Revenue, (US$, Mn), 2023-2028
    Table 36. By Region - Asia Cancidas Sales, (K Units), 2017-2022
    Table 37. By Region - Asia Cancidas Sales, (K Units), 2023-2028
    Table 38. By Country - South America Cancidas Revenue, (US$, Mn), 2017-2022
    Table 39. By Country - South America Cancidas Revenue, (US$, Mn), 2023-2028
    Table 40. By Country - South America Cancidas Sales, (K Units), 2017-2022
    Table 41. By Country - South America Cancidas Sales, (K Units), 2023-2028
    Table 42. By Country - Middle East & Africa Cancidas Revenue, (US$, Mn), 2017-2022
    Table 43. By Country - Middle East & Africa Cancidas Revenue, (US$, Mn), 2023-2028
    Table 44. By Country - Middle East & Africa Cancidas Sales, (K Units), 2017-2022
    Table 45. By Country - Middle East & Africa Cancidas Sales, (K Units), 2023-2028
    Table 46. Fresenius SE & Co. KGaA (Fresenius Kabi) Corporate Summary
    Table 47. Fresenius SE & Co. KGaA (Fresenius Kabi) Cancidas Product Offerings
    Table 48. Fresenius SE & Co. KGaA (Fresenius Kabi) Cancidas Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 49. Alvogen Inc. Corporate Summary
    Table 50. Alvogen Inc. Cancidas Product Offerings
    Table 51. Alvogen Inc. Cancidas Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 52. Juno Pharmaceuticals (MDA Inc.) Corporate Summary
    Table 53. Juno Pharmaceuticals (MDA Inc.) Cancidas Product Offerings
    Table 54. Juno Pharmaceuticals (MDA Inc.) Cancidas Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 55. Cipla Inc. Corporate Summary
    Table 56. Cipla Inc. Cancidas Product Offerings
    Table 57. Cipla Inc. Cancidas Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 58. Merck & Co., Inc. Corporate Summary
    Table 59. Merck & Co., Inc. Cancidas Product Offerings
    Table 60. Merck & Co., Inc. Cancidas Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 61. Athenex, Inc. Corporate Summary
    Table 62. Athenex, Inc. Cancidas Product Offerings
    Table 63. Athenex, Inc. Cancidas Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 64. Sanofi S.A. Corporate Summary
    Table 65. Sanofi S.A. Cancidas Product Offerings
    Table 66. Sanofi S.A. Cancidas Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 67. Sundent Pharmaceutical Co. Ltd. Corporate Summary
    Table 68. Sundent Pharmaceutical Co. Ltd. Cancidas Product Offerings
    Table 69. Sundent Pharmaceutical Co. Ltd. Cancidas Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 70. Gland Pharma Limited Corporate Summary
    Table 71. Gland Pharma Limited Cancidas Product Offerings
    Table 72. Gland Pharma Limited Cancidas Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 73. Sun Pharmaceutical Industries Ltd. Corporate Summary
    Table 74. Sun Pharmaceutical Industries Ltd. Cancidas Product Offerings
    Table 75. Sun Pharmaceutical Industries Ltd. Cancidas Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
    Table 76. Cancidas Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
    Table 77. Global Cancidas Capacity Market Share of Key Manufacturers, 2020-2022
    Table 78. Global Cancidas Production by Region, 2017-2022 (K Units)
    Table 79. Global Cancidas Production by Region, 2023-2028 (K Units)
    Table 80. Cancidas Market Opportunities & Trends in Global Market
    Table 81. Cancidas Market Drivers in Global Market
    Table 82. Cancidas Market Restraints in Global Market
    Table 83. Cancidas Raw Materials
    Table 84. Cancidas Raw Materials Suppliers in Global Market
    Table 85. Typical Cancidas Downstream
    Table 86. Cancidas Downstream Clients in Global Market
    Table 87. Cancidas Distributors and Sales Agents in Global Market
List of Figures
    Figure 1. Cancidas Segment by Type
    Figure 2. Cancidas Segment by Application
    Figure 3. Global Cancidas Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Cancidas Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Cancidas Revenue, 2017-2028 (US$, Mn)
    Figure 7. Cancidas Sales in Global Market: 2017-2028 (K Units)
    Figure 8. The Top 3 and 5 Players Market Share by Cancidas Revenue in 2021
    Figure 9. By Type - Global Cancidas Sales Market Share, 2017-2028
    Figure 10. By Type - Global Cancidas Revenue Market Share, 2017-2028
    Figure 11. By Type - Global Cancidas Price (US$/Unit), 2017-2028
    Figure 12. By Application - Global Cancidas Sales Market Share, 2017-2028
    Figure 13. By Application - Global Cancidas Revenue Market Share, 2017-2028
    Figure 14. By Application - Global Cancidas Price (US$/Unit), 2017-2028
    Figure 15. By Region - Global Cancidas Sales Market Share, 2017-2028
    Figure 16. By Region - Global Cancidas Revenue Market Share, 2017-2028
    Figure 17. By Country - North America Cancidas Revenue Market Share, 2017-2028
    Figure 18. By Country - North America Cancidas Sales Market Share, 2017-2028
    Figure 19. US Cancidas Revenue, (US$, Mn), 2017-2028
    Figure 20. Canada Cancidas Revenue, (US$, Mn), 2017-2028
    Figure 21. Mexico Cancidas Revenue, (US$, Mn), 2017-2028
    Figure 22. By Country - Europe Cancidas Revenue Market Share, 2017-2028
    Figure 23. By Country - Europe Cancidas Sales Market Share, 2017-2028
    Figure 24. Germany Cancidas Revenue, (US$, Mn), 2017-2028
    Figure 25. France Cancidas Revenue, (US$, Mn), 2017-2028
    Figure 26. U.K. Cancidas Revenue, (US$, Mn), 2017-2028
    Figure 27. Italy Cancidas Revenue, (US$, Mn), 2017-2028
    Figure 28. Russia Cancidas Revenue, (US$, Mn), 2017-2028
    Figure 29. Nordic Countries Cancidas Revenue, (US$, Mn), 2017-2028
    Figure 30. Benelux Cancidas Revenue, (US$, Mn), 2017-2028
    Figure 31. By Region - Asia Cancidas Revenue Market Share, 2017-2028
    Figure 32. By Region - Asia Cancidas Sales Market Share, 2017-2028
    Figure 33. China Cancidas Revenue, (US$, Mn), 2017-2028
    Figure 34. Japan Cancidas Revenue, (US$, Mn), 2017-2028
    Figure 35. South Korea Cancidas Revenue, (US$, Mn), 2017-2028
    Figure 36. Southeast Asia Cancidas Revenue, (US$, Mn), 2017-2028
    Figure 37. India Cancidas Revenue, (US$, Mn), 2017-2028
    Figure 38. By Country - South America Cancidas Revenue Market Share, 2017-2028
    Figure 39. By Country - South America Cancidas Sales Market Share, 2017-2028
    Figure 40. Brazil Cancidas Revenue, (US$, Mn), 2017-2028
    Figure 41. Argentina Cancidas Revenue, (US$, Mn), 2017-2028
    Figure 42. By Country - Middle East & Africa Cancidas Revenue Market Share, 2017-2028
    Figure 43. By Country - Middle East & Africa Cancidas Sales Market Share, 2017-2028
    Figure 44. Turkey Cancidas Revenue, (US$, Mn), 2017-2028
    Figure 45. Israel Cancidas Revenue, (US$, Mn), 2017-2028
    Figure 46. Saudi Arabia Cancidas Revenue, (US$, Mn), 2017-2028
    Figure 47. UAE Cancidas Revenue, (US$, Mn), 2017-2028
    Figure 48. Global Cancidas Production Capacity (K Units), 2017-2028
    Figure 49. The Percentage of Production Cancidas by Region, 2021 VS 2028
    Figure 50. Cancidas Industry Value Chain
    Figure 51. Marketing Channels
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
73
Frequently Asked Questions
Cancidas Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Cancidas Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Cancidas Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports